Showing 7791-7800 of 9550 results for "".
- Kerecis Introduces Fish-Skin Graft and Silicone Cover for Wound Treatmenthttps://practicaldermatology.com/news/kerecis-introduces-fish-skin-graft-and-silicone-cover-for-wound-treatment/2461686/Kerecis rolled out MariGen Shield, a treatment which integrates the company’s fish-skin graft with a silicone contact layer for treating chronic and complex wounds. The company also announced the results of a clinical study comparing the effectiveness of the Kerecis fish
- Maintaining Normal Vitamin D Levels May Benefit Melanoma Patients on Immunotherapyhttps://practicaldermatology.com/news/maintaining-normal-vitamin-d-levels-may-benefit-melanoma-patients-on-immunotherapy/2461677/Patients with advanced skin cancer should make extra efforts to maintain normal vitamin D levels when receiving immune checkpoint inhibitors, according to a study in
- Rodan + Fields Gives Back: Company Joins The Recycling Partnershiphttps://practicaldermatology.com/news/rodan-fields-gives-back-company-joins-the-recycling-partnership/2461673/Rodan + Fields, LLC. is joining 80 leading companies to support The Recycling Partnership, a nonprofit organization committed to building a better recycling system. Investing in The Recycling Partnership will help strengthen recycling access, education and infrastructure, advance
- Skin Cancer Foundation Hits the Road: Destination Healthy Skin Program Kicks Off on May 6, 2023https://practicaldermatology.com/news/skin-cancer-foundation-hits-the-road-destination-healthy-skin-program-kicks-off-on-may-6-2023/2461669/The Skin Cancer Foundation will launch its annual mobile education and screening program, Destination Healthy Skin, on Saturday, May 6, in Greenwich, Connecticut. The program educates the public about the importance of skin cancer early detection and effective sun p
- USPSTF Final Recommendation: There’s Not Enough Evidence to Support Skin Cancer Screening in Folks Without Symptomshttps://practicaldermatology.com/news/uspstf-final-recommendation-theres-not-enough-evidence-to-support-skin-cancer-screening-in-folks-without-symptoms/2461665/
- FDA Clears New Underarm Sweat Control Patchhttps://practicaldermatology.com/news/fda-clears-new-underarm-sweat-control-patch/2461660/The U.S. Food and Drug Administration (FDA) has cleared cleared Brella, the first 3-Minute SweatControl Patch to significantly reduce excessive underarm sweating in adults with primary axillary hyperhidrosis. The Brella SweatControl Patch provide
- Almirall to Assess Wellbeing in Psoriasis Studyhttps://practicaldermatology.com/news/almirall-to-assess-wellbeing-in-psoriasis-study/2461658/
- News You Can Use: BI Receives Permanent J-Code (J1747) for SPEVIGO Injectionhttps://practicaldermatology.com/news/news-you-can-use-bi-receives-permanent-j-code-j1747-for-spevigo-injection/2461649/The U.S. Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-code (J1747) for Boehringer Ingelheim’s SPEVIGO (spesolimab-sbzo) Injection, indicated for the treatment of generalized pustular psoriasis (GPP) flares in adults. The J-code for SPEVIGO became eff
- Xylyx Bio's Matrikynes Improves the Structure, Function, and Appearance of Skinhttps://practicaldermatology.com/news/xylyx-bios-matrikynes-improves-the-structure-function-and-appearance-of-skin/2461645/Xylyx Bio’s
- PHC Corporation, NovaScan Collab Set to Explore NMSC Detection Devicehttps://practicaldermatology.com/news/phc-corporation-novascan-collab-set-to-explore-nmsc-detection-device/2461644/PHC Corporation and